What is NDC 69932-002?

69932-002 is the product NDC for Posluma (flotufolastat f-18), Flotufolastat f-18 158 mCi/mL injection, listed with the FDA by Blue Earth Diagnostics. It has 1 package NDC, shown above in 10- and 11-digit form.

Blue Earth Diagnostics, NDC labeler code 69932. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Posluma?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Posluma NDC 69932-002 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69932-002Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69932-0002Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69932-002-50	69932000250	25 mL in 1 VIAL, MULTI-DOSE (69932-002-50)Marketed from May 25, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Posluma
Generic name (nonproprietary): flotufolastat f-18
Active ingredients: Flotufolastat f-18 — 158 mCi/mL
Dosage form: Injection
Route: Intravenous
Labeler: Blue Earth DiagnosticsNDC labeler code 69932
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 216023
Marketing start: May 25, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Positron Emitting Activity (Mechanism)
Identifiers: Product ID 69932-002_67cbcafa-00b3-41fd-986d-1159706273f3SPL ID 67cbcafa-00b3-41fd-986d-1159706273f3SPL set ID 907ac4a4-a088-4826-ab50-cfc31985c9d4UNII 811W19E3OL
Pharmacologic class: Radioactive Diagnostic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N469932000250 followed by a unit qualifier and the quantity

Package 69932-0002-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 25, 2026.

Indications (excerpt from the label)

POSLUMA is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. POSLUMA is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69932-002

What is NDC 69932-002?: 69932-002 is the product NDC for Posluma (flotufolastat f-18), Flotufolastat f-18 158 mCi/mL injection, listed with the FDA by Blue Earth Diagnostics. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Posluma (Flotufolastat F-18).
What is the active ingredient?: Flotufolastat f-18.
Who is the labeler?: Blue Earth Diagnostics, NDC labeler code 69932. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Posluma?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Posluma (Flotufolastat f-18) NDC 69932-002